PIP Sector: Healthcare---Industry: Biotechnology

[setravis]

Why Pharmathene Could Go From $2 to $20

See SIGA Thread.......


52wk Range: 1.13 - 4.23
Volume: 22,685,355
Avg Vol (3m): 511,336

Technicals
Record Volume
Most Actives
Percentage Gainer

Last Price Quote is:
78.45%above 13-day MA
104.11%above 50-day MA

[setravis]

Profile 

PharmAthene, Inc.
One Park Place
Suite 450
Annapolis, MD 21401
United States - Map
Phone: 410-269-2600
Fax: 410-269-2601
Website: http://www.pharmathene.com

Details   
Index Membership: N/A
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 147


Business Summary   
PharmAthene, Inc., a biodefense company, together with its subsidiaries, engages in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States. Its product candidates include SparVax, a recombinant protective antigen (rPA) anthrax vaccine to protect against inhalation anthrax that has completed one Phase I and two Phase II clinical trials; and Valortim, a human monoclonal antibody to protect against and treat human inhalational anthrax, which has completed Phase I clinical trial. The company’s product candidates also include Protexia, a recombinant enzyme (butyrylcholinesterase), which mimics a natural bioscavenger for the prevention or treatment of nerve agent poisoning by organophosphate compounds, including nerve gases and pesticides. In addition, its product candidates include RypVax, a recombinant plague vaccine comprising separate recombinant F1 (rF1) and V (rV) antigens produced in Escherichia coli, which completed three Phase I human clinical trials; and rPA anthrax vaccine, which does not require refrigeration. The company’s customers include National Institute of Allergy and Infectious Diseases, the U.S. Department of Defense, Biomedical Advanced Research and Development Authority, and the U.S. National Institutes of Health. It has a collaboration agreement with Medarex, Inc. to develop and commercialize Valortim. PharmAthene, Inc. was founded in 2001 and is based in Annapolis, Maryland.